Balyasny Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-426,462	Closed	-$6.93M	–	2821
2025 Q4	$6.93M	Buy	+426,462	New	+$6.96M	0.01%	1219
2025 Q1	–	Sell	-53,170	Closed	-$319K	–	2739
2024 Q4	$319K	Buy	+53,170	New	+$293K	﹤0.01%	2362
2024 Q3	–	Sell	-29,227	Closed	-$106K	–	2692
2024 Q2	$106K	Buy	29,227 +9,341	+47%	+$29.6K	﹤0.01%	2399
2024 Q1	$63.8K	Buy	+19,886	New	+$76.9K	﹤0.01%	2515
2022 Q3	–	Sell	-618,658	Closed	-$5M	–	2810
2022 Q2	$5M	Buy	+618,658	New	+$5.44M	0.02%	934
2022 Q1	–	Sell	-76,324	Closed	-$2.14M	–	2434
2021 Q4	$2.14M	Sell	76,324 -61,932	-45%	-$1.9M	0.01%	1181
2021 Q3	$4.7M	Buy	138,256 +99,222	+254%	+$3.59M	0.02%	843
2021 Q2	$1.59M	Buy	+39,034	New	+$1.52M	0.01%	1088
2021 Q1	–	Sell	-50,521	Closed	-$2.99M	–	1710
2020 Q4	$2.99M	Sell	50,521 -132,113	-72%	-$6.81M	0.02%	783
2020 Q3	$8.88M	Buy	182,634 +161,731	+774%	+$6.8M	0.08%	421
2020 Q2	$1.01M	Buy	+20,903	New	+$762K	0.01%	830
2020 Q1	–	Sell	-424,087	Closed	-$12.7M	–	1116
2019 Q4	$12.7M	Buy	+424,087	New	+$12.2M	0.08%	360